
ARDAT Consortium | AAV Serotype IVDs for patient selection in gene therapy development: technical and regulatory considerations
Asphalion experts Jon Giblin and Christopher Mann, together with experts from the ARDAT Consortium, have just published

Asphalion experts Jon Giblin and Christopher Mann, together with experts from the ARDAT Consortium, have just published

After four years of research into Polyendocrine Metabolic Ovarian Syndrome (PMOS) (previously known as polycystic ovary syndrome

Our Horizon Europe Projects GreenNanoBone and Medics made it to BioSpain 2026! During the event, our team

Our Horizon Europe Project PragmaTIL made it to World Patient Safety Congress! During the event, our team

Asphalion Contributes to a Joint EU Policy Brief Supporting a Greener Pharmaceutical Future

This week, our regulatory experts, Maria Castellà and Alejandro Ballester, participated in the first consortium meeting of

The objective of this project is to create a siRNA-combined advanced therapy, which will allow a more personalised treatment for the different stages of osteoarthritis. All siNPAIN partners are working hard to develop an efficient therapy to improve the quality of life of those affected by osteoarthritis, a chronic joint condition that affects more and more people every year.

HYDROHEAL innovates with hydrogel formulations to address bone strength challenges by treating vertebral and alveolar fractures.
Search or filter

By department
By stage of development
By product
By region
Other services
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
